SCHEMBL21165693

SCHEMBL21165693

c1ccc(-c2ccc(-n3c4ccc(-c5ccc6c(c5)c5cc(-c7ccccc7)ccc5n6-c5cc(-c6ccccc6)ccc5-c5ccccc5)cc4c4c(-c5cccc(-c6ccccc6)c5)cccc43)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 3/20 0.37
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TSPO P30536 1/20 0.34
HDAC4 P56524 1/20 0.34
PDE6D O43924 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
MAPK14 Q16539 1/20 0.32
CAMKK2 Q96RR4 1/20 0.31
MEN1 O00255 1/20 0.31
APAF1 O14727 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
XBP1 P17861 1/20 0.31
PTBP1 P26599 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21165586 0.98 KDM4E (0.40) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165580 0.98 KDM4E (0.40) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165607 0.98 KDM4E (0.40) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165701 0.98 KDM4E (0.40) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165627 0.97 L3MBTL1 (0.38) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165608 0.97 L3MBTL1 (0.38) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165674 0.97 ATM (0.37) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165595 0.96 ATM (0.41) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165615 0.95 ATM (0.41) ALKATML3MBTL1KDM4ETSPO
SCHEMBL21165699 0.95 ALK (0.37) ALKATML3MBTL1KDM4ETSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, MCM4 ALK 4595/4885ATM 1310/4885L3MBTL1 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.